🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tycel Phillips

City Of Hope National Medical Center

ORCID: 0000-0003-2143-9672

Also affiliated with City of Hope

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma*”.

Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma*

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1907371
N/A
0.494DataRank · unranked
7 citations

Tycel Phillips, Leslie Popplewell, Sven de Vos, Saurabh Chhabra, Amy Kimball +8 more

Taking the EZ way: Targeting enhancer of zeste homolog 2 in B-cell lymphomas

Blood Reviews(2022)10.1016/j.blre.2022.100988
N/A
0.477DataRank · unranked
23 citations

Gilles Salles, Connie Lee Batlevi, Hervé Tilly, Aristeidis Chaidos, Tycel Phillips +3 more

American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.03.001
N/A
0DataRank · unranked
16 citations

Mehdi Hamadani, Ambuj Kumar, Peter Dreger, Jonathan W. Friedberg, Martin Dreyling +29 more

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Leukemia(2021)10.1038/s41375-021-01193-6
N/A
0DataRank · unranked
83 citations

Luca Castagna, Laura Giordano, Vincent T. Ho, Paolo Corradini, Anna Guidetti +61 more

Durable responses with ALK inhibitors for primary refractory anaplastic lymphoma Kinase-positive large B-cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022007537
N/A
0DataRank · unranked
9 citations

Tycel Phillips, Radhika Takiar

TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma

Haematologica(2023)10.3324/haematol.2023.283074
N/A
0DataRank · unranked
0 citations

David A. Bond, Adam S. Kittai, Neda Amirmokhtari, Abigail Steinbrunner, Allison Huffman +6 more

A real-world experience: Outcomes among relapsed/refractory diffuse large B cell lymphoma patients with CD20 loss.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e19570
N/A
0DataRank · unranked
0 citations

Philip S. Boonstra, Yasmin Karimi, Shannon A. Carty, Ryan A. Wilcox, Tycel Phillips +1 more

Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study

Haematologica(2021)10.3324/haematol.2020.270876
N/A
0DataRank · unranked
42 citations

Andrew M. Evens, Alexey V. Danilov, Stephen D. Smith, Deepa Jagadeesh, Lori A. Leslie +52 more